The 16th Annual Johns Hopkins Multiple Sclerosis Symposium Series – Baltimore

DESCRIPTION
Join our panel of experts for an interactive, live CME-/CNE-certified workshop exploring multidisciplinary strategies to enhance the diagnosis and management of multiple sclerosis (MS) in the rapidly evolving treatment landscape. This event features distinct tracks for specialists and primary care providers. Topics will include early recognition and differential diagnosis, the latest insights from clinical trials and real-world data on disease-modifying treatment options, and avenues to foster collaborative care and shared decision-making. Don’t miss this unique opportunity to engage directly with leaders in the field and ensure your practice remains at the forefront of advancements in MS care.

WHO SHOULD ATTEND
This activity is intended for neurologists, primary care physicians, nurse practitioners, physician assistants, and nurses, as well as other healthcare providers who manage patients with MS.

LEARNING OBJECTIVES
After attending this activity, the learner will demonstrate the ability to:

Multidisciplinary Joint Session

• Evaluate strategies that support prompt differential diagnosis of MS to ensure effective
  treatment initiation.
• Describe current concepts of disease-modifying therapy (DMT) management for
  relapsing MS, including different treatment strategies (immune reconstitution therapy and
  early aggressive vs escalation approaches).
• Assess the most recent efficacy and safety data on DMTs approved for relapsing and
  progressive forms of MS.
• Explain how to effectively integrate shared decision-making and collaborative care into MS
  management plans.

Specialist Track

• Identify imaging characteristics and other distinguishing clinical features that can be used
  to differentiate MS from other demyelinating neurologic disorders to guide appropriate
  treatment.
• Select appropriate treatment, considering personalized benefit-to-risk profiles and shared
  decision-making, for individual patients with MS or other demyelinating disorders.
• Describe the mechanism of action and available data for investigational agents in MS.

Primary Care Track

• Apply best practices in the symptomatic management in MS.
• Implement strategies to provide whole-person care, beyond disease-specific
  management, for those living with MS.